Filing Flows › Pulse Biosciences (PLSE) › Q3 2025
Pulse Biosciences (PLSE) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 5, 2025
Pulse Biosciences (PLSE) reported revenue of $86K for the third quarter 2025 (Q3 2025).
Pulse Biosciences, Q3 2025: revenue $86K, net loss $19.4M, operating cash flow −$13.0M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $86K | — | — |
| Operating profit | −$20.4M | — | — |
| Net earnings | −$19.4M | — | — |
| Operating cash flow | −$13.0M | — | — |
What changed
Revenue was $86K in Q3 2025.
Operating costs exceeded revenue by $20.4M, an operating margin of -23682.6%. The quarter ended with a net loss of $19.4M.
Operating cash flow was −$13.0M. Non-cash charges added back $266K of depreciation and amortization and $5.6M of share-based compensation. Capital expenditures of $62K exceeded it, leaving free cash flow of −$13.1M.
Questions
What was Pulse Biosciences' revenue in the third quarter 2025?
Pulse Biosciences (PLSE) reported revenue of $86K for the third quarter 2025 (Q3 2025).
Source: Pulse Biosciences 10-Q on SEC EDGAR.